- Open
- 24.72
- High
- 24.72
- Low
- 24.10
- Close
- 24.60
- Change
- -0.10 (-0.41%)
- Volume
- 67,293
| 29 Sept 2026 | 07:00:07 | Share Buyback |
| 28 Sept 2026 | 07:00:07 | Share Buyback |
| 21 Sept 2026 | 15:37:18 | Holding(s) in Company |
| 15 Sept 2026 | 07:00:04 | Interim Results |
| 3 Sept 2026 | 07:00:04 | Share Buyback |
| 24 Jun 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 6 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 4 Jun 2024 | Annual Report and Accounts (to 2023-12-31) |
EKF Diagnostics Holdings plc manufactures point-of-care diagnostics and life sciences products, providing solutions that enhance patient care and scientific research. The company offers a range of in vitro diagnostic (IVD) analyzers and tests, including those for hematology, diabetes, and metabolic conditions, serving healthcare providers in over 120 countries. EKF also supplies enzymes, reagents, and biomaterials for diagnostic and pharmaceutical applications, utilizing advanced fermentation and bioprocessing technologies to meet the needs of its clients in the clinical and biotech sectors.
Lord Howard of Rising has interests in this issuer
| 29 Sept 2026 | 07:00:07 | Share Buyback |
| 28 Sept 2026 | 07:00:07 | Share Buyback |
| 21 Sept 2026 | 15:37:18 | Holding(s) in Company |
| 15 Sept 2026 | 07:00:04 | Interim Results |
| 3 Sept 2026 | 07:00:04 | Share Buyback |
| 24 Jun 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 6 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 4 Jun 2024 | Annual Report and Accounts (to 2023-12-31) |
EKF Diagnostics Holdings plc manufactures point-of-care diagnostics and life sciences products, providing solutions that enhance patient care and scientific research. The company offers a range of in vitro diagnostic (IVD) analyzers and tests, including those for hematology, diabetes, and metabolic conditions, serving healthcare providers in over 120 countries. EKF also supplies enzymes, reagents, and biomaterials for diagnostic and pharmaceutical applications, utilizing advanced fermentation and bioprocessing technologies to meet the needs of its clients in the clinical and biotech sectors.
Lord Howard of Rising has interests in this issuer
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.94bn | +0.5% | |
| £173m | +0.2% | |
EKFEKF Diagnostics Holdings plc | £105m | -0.1% |
| £97m | -0.3% | |
| £28m | -0.0% | |
| £11m | -0.7% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.94bn | +0.5% | |
| £173m | +0.2% | |
EKFEKF Diagnostics Holdings plc | £105m | -0.1% |
| £97m | -0.3% | |
| £28m | -0.0% | |
| £11m | -0.7% |
